Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$637M |
| 2 |
Weyerhaeuser
WY
|
+$340M |
| 3 |
IQVIA
IQV
|
+$132M |
| 4 |
Halliburton
HAL
|
+$123M |
| 5 |
Dover
DOV
|
+$112M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$3.68B |
| 2 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$708M |
| 3 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$460M |
| 4 |
RAI
Reynolds American Inc
RAI
|
+$293M |
| 5 |
Gilead Sciences
GILD
|
+$246M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 6.22% |
| 2 | Healthcare | 5.12% |
| 3 | Financials | 4.53% |
| 4 | Consumer Discretionary | 4.09% |
| 5 | Communication Services | 3.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
5501
Hackett Group
HCKT
$285M
| $31K | ﹤0.01% |
2,101
+1,805
| +610% | +$26.9K |
|
5502
CALL
Idexx Laboratories
IDXX
$44.8B
| $31K | ﹤0.01% |
200
+100
| +100% | +$15.8K |
|
5503
Moelis & Co
MC
$5.08B
| $31K | ﹤0.01% |
724
-1,496
| -67% | -$59.9K |
|
5504
CALL
Owens Corning
OC
$11.5B
| $31K | ﹤0.01% |
400
-1,500
| -79% | -$105K |
|
5505
PUT
ProShares UltraShort QQQ
QID
$264M
| $31K | ﹤0.01% |
25
+11
| +79% | +$14.1K |
|
5506
Cartesian Therapeutics
RNAC
$231M
| $31K | ﹤0.01% |
56
+4
| +8% | +$2.13K |
|
5507
CALL
Service Corp International
SCI
$11.7B
| $31K | ﹤0.01% |
+900
| New | +$31.2K |
|
|
SNBR
5508
PUT
DELISTED
Sleep Number
SNBR
| $31K | ﹤0.01% |
+1,000
| New | +$31.2K |
|
5509
TriMas Corp
TRS
$1.45B
| $31K | ﹤0.01% |
1,134
-2,973
| -72% | -$71.3K |
|
5510
CALL
Zumiez
ZUMZ
$345M
| $31K | ﹤0.01% |
1,700
-25,800
| -94% | -$351K |
|
|
SIX
5511
DELISTED
Six Flags Entertainment Corp.
SIX
| $31K | ﹤0.01% |
511
-735
| -59% | -$41.2K |
|
|
GCP
5512
CALL
DELISTED
GCP Applied Technologies Inc.
GCP
| $31K | ﹤0.01% |
1,000
| – | – |
|
|
CVO
5513
DELISTED
Cenevo, Inc.
CVO
| $31K | ﹤0.01% |
9,063
-33,400
| -79% | -$152K |
|
|
RESI
5514
DELISTED
Front Yard Residential Corporation Common Stock
RESI
| $31K | ﹤0.01% |
2,745
-310,194
| -99% | -$3.78M |
|
|
AFMD
5515
DELISTED
Affimed
AFMD
| $30K | ﹤0.01% |
1,339
| – | – |
|
5516
Adecoagro
AGRO
$1.37B
| $30K | ﹤0.01% |
2,739
-8,975
| -77% | -$89.9K |
|
5517
Akebia Therapeutics
AKBA
$351M
| $30K | ﹤0.01% |
1,568
-12,330
| -89% | -$190K |
|
5518
PUT
A.O. Smith
AOS
$8.25B
| $30K | ﹤0.01% |
500
-100
| -17% | -$5.61K |
|
5519
Central Garden & Pet Co Class A
CENTA
$2.39B
| $30K | ﹤0.01% |
1,023
-13,240
| -93% | -$351K |
|
5520
Charles River Laboratories
CRL
$11.1B
| $30K | ﹤0.01% |
282
-775
| -73% | -$79.6K |
|
5521
PUT
Darling Ingredients
DAR
$9.5B
| $30K | ﹤0.01% |
1,700
| – | – |
|
|
EMX
5522
DELISTED
EMX Royalty
EMX
| $30K | ﹤0.01% |
+36,000
| New | +$33.8K |
|
5523
CALL
Fabrinet
FN
$16.3B
| $30K | ﹤0.01% |
800
-2,100
| -72% | -$85.9K |
|
5524
PUT
Flotek Industries
FTK
$968M
| $30K | ﹤0.01% |
1,083
+766
| +242% | +$30.3K |
|
5525
Houlihan Lokey
HLI
$8.77B
| $30K | ﹤0.01% |
753
-2,822
| -79% | -$103K |
|
Similar funds
Barclays's Q3 2017 Portfolio in Review
As of Q3 2017, Barclays held 7,380 positions worth $97.1B, up 4% from $93.4B the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Barclays's Q3 2017 filing shows 424 new, 3,249 increased, 2,816 reduced and 405 closed positions. Its largest new stake was Crown Castle International Corp. 6.875% Mandatory Convertible Preferred Stock, Series A: 39,656 shares worth $42.4M. The largest sale was Invesco QQQ Trust, an estimated $3.68B.
By sector, the portfolio is most concentrated in Technology at 6.2% of assets, up from 6.1% a quarter earlier, followed by Healthcare and Financials.
- Barclays's largest Q3 2017 buy was Crown Castle International Corp. 6.875% Mandatory Convertible Preferred Stock, Series A: 39,656 shares worth $42.4M.
- Barclays added most to State Street SPDR S&P 500 ETF Trust in Q3 2017, an estimated $637M increase.
- Barclays's biggest Q3 2017 reduction was Invesco QQQ Trust, cutting an estimated $3.68B.
- Barclays fully exited Reynolds American Inc in Q3 2017, selling an estimated $293M.
- Barclays's ten largest holdings make up 29% of its $97.1B portfolio in Q3 2017.
- Barclays opened 424 new positions and closed 405 in Q3 2017.
- Barclays's portfolio value rose 4% quarter-over-quarter to $97.1B.
Based on Barclays's 13F filing for Q3 2017, filed 14 Nov 2017.